Barclays »

Vor Biopharma shares owned by Barclays

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Barclays

Quarter filed Position value Share count Share price at filing
2025-12-31 $18k 1.4k 13.08

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corp Opt Put Option (MSFT)
Apple (AAPL)
Ishares Tr Opt Call Option (IWM)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
Facebook Inc cl a (META)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Opt Put Option (HYG)
Advanced Micro Devices (AMD)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Vor Biopharma

Fcpm Iii Services B.v.
Frazier Life Sciences Management
RA Capital Management
VR Adviser
Paradigm Biocapital Advisors
Dr. Jeffrey R. Jay, M.D.
Susquehanna International
Caligan Partners
Vanguard Group
BlackRock
Sphera Funds Management
Laurion Capital Management
UBS Group
FMR
Findell Capital Management

View all funds holding Vor Biopharma